Literature DB >> 11583787

Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.

A Küng1, D B Strickmann, M Galanski, B K Keppler.   

Abstract

Capillary electrophoresis as well as ESI-MS has been applied for investigating the influence of the sulfur-containing amino acids L-cysteine and L-methionine on the binding behavior of oxaliplatin (trans-R,R-diaminocyclohexane(oxalato)platinum(II)), cisplatin (cis-diamminedichloroplatinum(II)), carboplatin (cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II)), cis-diammine(malonato)platinum(II) and cis-diammine(2-hydroxymalonato)platinum(II) to 5'-GMP. The presence of L-methionine resulted in a different kind of adduct formation which involves ammine release due to the trans-effect of sulfur. In addition, the time-dependent behavior of the reaction with 5'-GMP changed significantly. Due to the high stability of the diaminocyclohexane (DACH) platinum fragment, oxaliplatin showed a completely different behavior in comparison to diammine platinum complexes. Formation of [Pt(DACH)(L-Met-S,N)](+) inhibits coordination of 5'-GMP. Displacement of L-Met by 5'-GMP does not occur. Differences concerning the mode of action of oxaliplatin are expected. Characterization of the analytes was performed by UV, NMR and mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583787     DOI: 10.1016/s0162-0134(01)00225-2

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  8 in total

1.  Identification of the adduct between a 4-Aza-3-ene-1,6-diyne and DNA using electrospray ionization mass spectrometry.

Authors:  Courtney L Sherman; Sarah E Pierce; Jennifer S Brodbelt; Bodin Tuesuwan; Sean M Kerwin
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-26       Impact factor: 3.109

2.  Cobalt complexes as internal standards for capillary zone electrophoresis-mass spectrometry studies in biological inorganic chemistry.

Authors:  Hannah U Holtkamp; Stuart J Morrow; Mario Kubanik; Christian G Hartinger
Journal:  J Biol Inorg Chem       Date:  2017-01-02       Impact factor: 3.358

3.  Comparison of N-acetylmethionine reactivity between oxaliplatin and an oxaliplatin derivative with chiral (S,S) amine nitrogen atoms.

Authors:  Kevin M Williams; Amy D Poynter; Jonathan D Hendrie; Daniel C Jackson; Virginia K Martin
Journal:  Inorganica Chim Acta       Date:  2013-05-24       Impact factor: 2.545

4.  Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management.

Authors:  Janaina Fernandes; Gisele Cardoso de Amorim; Tallita Eduarda da Veiga; Jesiel Cardoso; Alberto Cardoso Arruda; Mara Silvia Pinheiro Arruda; Morgana T L Castelo-Branco
Journal:  J Biol Inorg Chem       Date:  2019-04-27       Impact factor: 3.358

5.  Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

Authors:  Irina Buß; Ganna V Kalayda; Andreas Lindauer; Michael R Reithofer; Markus Galanski; Bernhard K Keppler; Ulrich Jaehde
Journal:  J Biol Inorg Chem       Date:  2012-03-29       Impact factor: 3.358

6.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

7.  RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.

Authors:  Jerry D Monroe; Satya A Moolani; Elvin N Irihamye; Joshua S Speed; Yann Gibert; Michael E Smith
Journal:  Cells       Date:  2020-12-08       Impact factor: 6.600

8.  Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity.

Authors:  Sophie Möltgen; Eleonora Piumatti; Giuseppe M Massafra; Sabine Metzger; Ulrich Jaehde; Ganna V Kalayda
Journal:  Cells       Date:  2020-05-26       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.